BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sflomos G, Schipper K, Koorman T, Fitzpatrick A, Oesterreich S, Lee AV, Jonkers J, Brunton VG, Christgen M, Isacke C, Derksen PWB, Brisken C. Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions. Cancers (Basel) 2021;13:5396. [PMID: 34771558 DOI: 10.3390/cancers13215396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Furth PA, Wang W, Kang K, Rooney BL, Keegan G, Muralidaran V, Zou X, Flaws JA. Esr1 but Not CYP19A1 Overexpression in Mammary Epithelial Cells during Reproductive Senescence Induces Pregnancy-Like Proliferative Mammary Disease Responsive to Anti-Hormonals. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.09.007] [Reference Citation Analysis]
2 Blawski R, Toska E. A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer. Cancer Res 2022;82:3668-70. [PMID: 36245246 DOI: 10.1158/0008-5472.CAN-22-2594] [Reference Citation Analysis]
3 Lee S, Osmanbeyoglu HU. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas. Breast Cancer Res 2022;24:54. [PMID: 35906698 DOI: 10.1186/s13058-022-01550-y] [Reference Citation Analysis]
4 Cheng GJ, Leung EY, Singleton DC. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2022.00084] [Reference Citation Analysis]
5 Van Baelen K, Geukens T, Maetens M, Tjan – Heijnen V, Lord C, Linn S, Bidard F, Richard F, Yang W, Steele R, Pettitt S, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-salomon A, Derksen P, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Lee S, Osmanbeyoglu HU. Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.. [DOI: 10.1101/2022.04.08.487589] [Reference Citation Analysis]